HWAM
PJP icon

Hennion & Walsh Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Hennion & Walsh Asset Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,950
Closed -$721K – 996
2026
Q1 		$721K Buy
+6,950
New +$734K 0.02% 592

Other funds holding PJP

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
CI
Cordant Inc Portland, Oregon $278M AUM 23.17% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Hennion & Walsh Asset Management's PJP Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 6,950 shares — an estimated $721K sold.

Hennion & Walsh Asset Management first reported a position in PJP in Q1 2026 and held it in 1 quarter. The position peaked at $721K in Q1 2026. 18 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Hennion & Walsh Asset Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 6,950 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $721K.
  • Hennion & Walsh Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and held it in 1 quarter.
  • Hennion & Walsh Asset Management's Invesco Pharmaceuticals ETF position peaked at $721K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.